Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313113 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ebony Hargrove-Wiley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Mice, Transgenic, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Janssen Scholars of Oncology Diversity Engagment Program, NIDDK NIH HHS.
Abstract (Originalsprache)
Breast cancer is commonly thought of as a “women’s disease”. However, men are increasingly diagnosed with the disease, and their mortality rates are disparately higher than those of female patients. The abundance and composition of the immune microenvironment are determinants of breast cancer progression and survival. It is well documented that there are sex-specific differences in the immune response to several diseases, including various cancers. However, the effects of these differences in the context of breast cancer remain to be explored. This study demonstrates sex differences in the hormonal and immune landscape of the MMTV-PyMT transgenic murine model of female and male ER+ breast cancer using single-cell RNA sequencing (scRNA-Seq), whole-slide immunohistochemistry, and flow cytometry. Mammary tumors of transgenic male mice had increased estrogen receptor alpha expression and enriched nuclear binding signatures compared to female tumors. In the tumor immune compartment, male mice had lower intratumoral leukocyte infiltration. Yet, scRNA-Seq analysis reveals a more immunostimulatory microenvironment and increased antitumor immune populations in the primary and metastatic lungs as compared to transgenic females. Despite a more favorable innate immune profile, the metastatic burden was increased in male mice. Our data support a sex-dependent immune response in mammary carcinoma associated with the tumor, and likely host, hormonal environment. With emerging therapeutics targeting the tumor immune microenvironment, characterizing immune profiles is critical for optimizing their use in all breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Program in Cancer Biology, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
- Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
ORCID-Profile: Ebony Hargrove-Wiley, Barbara Fingleton
Förderung
- NIGMS NIH HHS
- Janssen Scholars of Oncology Diversity Engagment Program
- NIDDK NIH HHS
- METAvivor
- NCRR NIH HHS
- NEI NIH HHS
- NCI NIH HHS
- National Science Foundation
Zitieren
APA
Hargrove-Wiley, E., Obodo, D., Bindeman, W., & Fingleton, B. (2024). Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313113
Vancouver
Hargrove-Wiley E, Obodo D, Bindeman W, Fingleton B. Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313113
BibTeX
@article{HargroveWiley2024,
author = {Hargrove-Wiley, Ebony and Obodo, Dora and Bindeman, Wendy and Fingleton, Barbara},
title = {Elucidating Sex-Specific Immune Profiles in a Breast Cancer Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313113}
}
EUVIMED